Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer
2022-02-21 13:00
Meihua International Medical Technologies Co., Ltd. Announces Closing of $39.4 Million Initial Public Offering
2022-02-19 05:30
OliPass Announces Commencement of Dosing in Phase 2a Trial for Pain Killer OLP-1002
2022-02-18 23:00
Keymed Bio Joins Hang Seng Family of Indexes
2022-02-18 22:10
TransThera Announces that the IND Application of TT-01488, a Non-covalent Reversible BTK Inhibitor, for the Treatment of B-Cell Lymphomas has been Approved by the FDA in the US and Officially Accepted by the NMPA in China
2022-02-18 22:00
PolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology
2022-02-18 08:19
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin's Lymphoma
2022-02-17 21:30
Flat Medical joins the Stay Connected(R), the International Organization for Safer Neuraxial Anesthesia
2022-02-17 21:00
Meihua International Medical Technologies Co., Ltd. Announces Pricing of $36,000,000 Initial Public Offering
2022-02-16 20:34
PharmaBlock Appoints Dr. Zhengtian Gu as Senior Vice President of Quality and Regulatory Affairs
2022-02-16 20:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team
2022-02-15 21:00
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg)
2022-02-15 16:00
AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases
2022-02-15 15:05
Largest Hospital in Queensland, Australia Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
2022-02-15 05:10
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by IASO Bio and Innovent
2022-02-14 08:25
Visionflex Chooses Vonage to Power its Next-Generation Remote Healthcare and Diagnostic Services
2022-02-14 06:32
Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results
2022-02-12 06:05
Kintor Pharma Announces First Patient Dosing in China in Phase III Clinical Trial of Proxalutamide for the Treatment of COVID-19 Outpatients
2022-02-11 20:40
WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories
2022-02-11 10:00
Ucello Therapeutics Completes US$25 Million Series A Financing
2022-02-11 02:16
1
173
174
175
176
177
801